secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2021-09-21T23:59:59+00:00
Accession:  0001728117-21-000092
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio promotes CFO Bryan Giraudo to also serve as COO
------------------------------------------------------------

- Bryan Giraudo appointed COO effective Sept 16, 2021, while remaining CFO.
- Annual base salary increased to $460,000; target bonus raised to 45% of salary.
- Granted option for 150,000 shares under 2019 Equity Incentive Plan; vests over 4 years.
- Severance enhanced: 9 months base salary (12 months upon change-in-control) plus bonus and COBRA.
- Giraudo joined Gossamer in May 2018 as CFO; previously Senior MD at SVB Leerink.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811721000092/0001728117-21-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811721000092/goss-20210916.htm
  HTML page:      https://secwatch.observer/filing/0001728117-21-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer